Expression of Survivin Does Not Appear to Influence Breast Cancer Recurrence Risk

BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells. METHODS: We estimated the association between nuclear and cytoplasmic survivin expression in primary t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Oncol
Auteurs principaux: Collin, Lindsay J, Cronin-Fenton, Deirdre P, Ahern, Thomas P, Christensen, Kristina B, Damkier, Per, Hamilton-Dutoit, Stephen, Kjærsgaard, Anders, Lauridsen, Kristina L, Yacoub, Rami, Christiansen, Peer, Sørensen, Henrik Toft, Lash, Timothy L
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386593/
https://ncbi.nlm.nih.gov/pubmed/30351173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2018.1503419
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires